Log In
BCIQ
Print this Print this
 

Osphena, ospemifene (Ophena)

  Manage Alerts
Collapse Summary General Information
Company QuatRx Pharmaceuticals Co.
DescriptionSelective estrogen receptor modulator (SERM)
Molecular Target Estrogen receptor 1 (ESR1)
Mechanism of ActionSelective estrogen receptor modulator (SERM)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMenopause
Indication DetailsTreat moderate to severe dyspareunia due to postmenopausal vulvovaginal atrophy; Treat moderate to severe vaginal dryness due to menopause; Treat postmenopausal vulvovaginal atrophy
Regulatory Designation
PartnerShionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$25.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2010

Undisclosed

$25.0M

Undisclosed

Get a free BioCentury trial today